Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Protein Kinase C delta (PKCd) | Login | Protein Kinase C delta (PKCd) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C epsilon (PKCe) | Login | Protein Kinase C epsilon (PKCe) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C epsilon (PKCe) | Login | Protein Kinase C epsilon (PKCe) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C gamma (PKCg) | Login | Protein Kinase C gamma (PKCg) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C gamma (PKCg) | Login | Protein Kinase C gamma (PKCg) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C, gamma (PKCg) | Login | Protein Kinase C, gamma (PKCg) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C eta (PKCeta) | Login | Protein Kinase C eta (PKCeta) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C eta (PKCeta) | Login | Protein Kinase C eta (PKCeta) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C theta (PKCtheta) | Login | Protein Kinase C theta (PKCtheta) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C zeta (PKCz) | Login | Protein Kinase C zeta (PKCz) | ||||||||||||||||
|
||||||||||||||||||
| Protein Kinase C zeta (PKCz) | Login | Protein Kinase C zeta (PKCz) | ||||||||||||||||
|
||||||||||||||||||
| Nkx 3.1 (NK-2 Family Homeodomain Transcription Factor) | Login | Nkx 3.1 (NK-2 Family Homeodomain Transcription Factor) | ||||||||||||||||
|
||||||||||||||||||
| Angiopoietin 1 (Agpt, ang1, Ang1, Ang-1, ANG-1, Angiopoietin-1) | Login | Angiopoietin 1 (Agpt, ang1, Ang1, Ang-1, ANG-1, Angiopoietin-1) | ||||||||||||||||
|
||||||||||||||||||
| Angiopoietin 2 (Ang-2, AGPT2, ANGPT2, Ang2) | Login | Angiopoietin 2 (Ang-2, AGPT2, ANGPT2, Ang2) | ||||||||||||||||
|
||||||||||||||||||
| BACH1 (BRCA1-Associated CT Helicase 1) | Login | BACH1 (BRCA1-Associated CT Helicase 1) | ||||||||||||||||
|
||||||||||||||||||
| BIVM, CT (Basic, Immunoglobulin-like Variable Motif-containing) | Login | BIVM, CT (Basic, Immunoglobulin-like Variable Motif-containing) | ||||||||||||||||
|
||||||||||||||||||
| CIITA (Class II Trans Activator, C2TA, CIITA IV, MHC2TA, MHC class II transactivator) | Login | CIITA (Class II Trans Activator, C2TA, CIITA IV, MHC2TA, MHC class II transactivator) | ||||||||||||||||
|
||||||||||||||||||
| Cox 2 (Cyclooxygenase-2, Prostaglandin H Synthase) | Login | Cox 2 (Cyclooxygenase-2, Prostaglandin H Synthase) | ||||||||||||||||
|
||||||||||||||||||
| Epidermal Growth Factor Receptor (erbB, EGFR) | Login | Epidermal Growth Factor Receptor (erbB, EGFR) | ||||||||||||||||
|
||||||||||||||||||
| Glucoamylase | Login | Glucoamylase | ||||||||||||||||
|
||||||||||||||||||
| Histone Methyltransferase Set7/9 (Histone H3 Lysine 4 Specific Methyltransferase, H3 K4 HMTase, H4 Lysine-4 Specific, Histone H3 K4 Methyltransferase, Histone Lysine N-methyltransferase H3 Lysine 4 Specific SET7, FLJ21193, KIAA1717, SET 7/9, SETD7) | Login | Histone Methyltransferase Set7/9 (Histone H3 Lysine 4 Specific Methyltransferase, H3 K4 HMTase, H4 Lysine-4 Specific, Histone H3 K4 Methyltransferase, Histone Lysine N-methyltransferase H3 Lysine 4 Specific SET7, FLJ21193, KIAA1717, SET 7/9, SETD7) | ||||||||||||||||
|
||||||||||||||||||
| HRD1 (1200010C09Rik, KIAA1810, MGC40372, Synovial Apoptosis Inhibitor 1 Synoviolin, Synoviolin 1) | Login | HRD1 (1200010C09Rik, KIAA1810, MGC40372, Synovial Apoptosis Inhibitor 1 Synoviolin, Synoviolin 1) | ||||||||||||||||
|
||||||||||||||||||
| IKAP, CT (IkB Associated Protein) | Login | IKAP, CT (IkB Associated Protein) | ||||||||||||||||
|
||||||||||||||||||
| JNK1 (Jun Kinase 1, c-Jun N-terminal Kinase, Stress Activated Protein Kinase alpha, SAPKa, JAK1A, JNK46, JNK1 alpha 2, JNK21B1/2, Mitogen Activated Protein Kinase 8, MAPK8, MK08, p54 gamma, PRKM8) | Login | JNK1 (Jun Kinase 1, c-Jun N-terminal Kinase, Stress Activated Protein Kinase alpha, SAPKa, JAK1A, JNK46, JNK1 alpha 2, JNK21B1/2, Mitogen Activated Protein Kinase 8, MAPK8, MK08, p54 gamma, PRKM8) | ||||||||||||||||
|
||||||||||||||||||
| Kallikrein 4 (Prostase, KLK4, Kallikrein-like Protein 1, KLK L1, KLK-L1, Enamel Matrix Serine Protease 1, EMSP1, HK4, Protease Serine 17, PRSS17, PSTS) | Login | Kallikrein 4 (Prostase, KLK4, Kallikrein-like Protein 1, KLK L1, KLK-L1, Enamel Matrix Serine Protease 1, EMSP1, HK4, Protease Serine 17, PRSS17, PSTS) | ||||||||||||||||
|
||||||||||||||||||


